NasdaqCM:ACHVBiotechs
Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Awards Rare Priority Voucher for Vaping Cessation Drug – Has the Bull Case Changed?
Achieve Life Sciences recently announced that the U.S. Food and Drug Administration awarded the company a rare Commissioner's National Priority Voucher, expediting the review of cytisinicline for nicotine dependence in e-cigarette or vaping cessation.
This first-of-its-kind designation, paired with Breakthrough Therapy status and promising clinical trial results, puts cytisinicline at the forefront of developing a dedicated treatment for vaping cessation, an area with significant unmet...